Dendritic cell vaccines in melanoma: From promise to proof?

Toll-like receptor signalling

2004 • 7,983 citations

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

2004 • 4,872 citations

Toll-like receptor control of the adaptive immune responses

2004 • 4,092 citations

Interleukin-12 and the regulation of innate resistance and adaptive immunity

2003 • 3,689 citations

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

1998 • 2,916 citations

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

2002 • 2,879 citations

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

2007 • 2,814 citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

2002 • 2,781 citations

CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs

1999 • 2,326 citations

The Biology of NKT Cells

2006 • 2,052 citations

Taking dendritic cells into medicine

2007 • 2,044 citations

Toll Pathway-Dependent Blockade of CD4 ⁺ CD25 ⁺ T Cell-Mediated Suppression by Dendritic Cells

2003 • 2,023 citations

Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

2006 • 2,010 citations

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

1996 • 1,854 citations

The B7–CD28 superfamily

2002 • 1,646 citations

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

2005 • 1,613 citations

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

2003 • 1,564 citations

Dendritic-cell control of pathogen-driven T-cell polarization

2003 • 1,413 citations

Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

2001 • 1,384 citations

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

2005 • 1,330 citations

Progress in human tumour immunology and immunotherapy

2001 • 1,327 citations

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

1999 • 1,260 citations

The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand

1997 • 1,224 citations

Dendritic cells as therapeutic vaccines against cancer

2005 • 1,195 citations

Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions

1997 • 1,179 citations

Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance

2002 • 1,176 citations

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

2000 • 1,175 citations

Steady-state and inflammatory dendritic-cell development

2006 • 1,172 citations

Dendritic cells in a mature age

2006 • 1,147 citations

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells

2005 • 1,142 citations

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections

2005 • 1,111 citations

CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO

2005 • 1,108 citations

Dendritic-cell trafficking to lymph nodes through lymphatic vessels

2005 • 1,071 citations

Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

2006 • 1,069 citations

Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection

2007 • 1,060 citations

Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

2001 • 1,033 citations

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

2005 • 998 citations

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

2005 • 997 citations

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

1976 • 951 citations

Dendritic cell immunotherapy: mapping the way

2004 • 948 citations

Lysosomal Glycosphingolipid Recognition by NKT Cells

2004 • 946 citations

In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination

2004 • 905 citations

Regulation of Dendritic Cell Migration to the Draining Lymph Node

2003 • 863 citations

Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking

1998 • 832 citations

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

2001 • 828 citations

Toll-dependent selection of microbial antigens for presentation by dendritic cells

2006 • 815 citations

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

2005 • 807 citations

CTLA-4 ligation blocks CD28-dependent T cell activation.

1996 • 787 citations

Helping the CD8+ T-cell response

2004 • 775 citations

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

2005 • 758 citations

PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells

2004 • 748 citations

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

2007 • 728 citations

Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein

2003 • 698 citations

Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo

2007 • 668 citations

Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells

2000 • 627 citations

Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression

2007 • 618 citations

Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

2005 • 616 citations

Cancer vaccines: between the idea and the reality

2003 • 616 citations

Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development

2006 • 615 citations

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

2005 • 584 citations

DC-based cancer vaccines

2007 • 581 citations

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

2001 • 535 citations

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

2006 • 527 citations

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

2002 • 490 citations

Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells

2002 • 484 citations

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

2003 • 479 citations

α-Type-1 Polarized Dendritic Cells

2004 • 471 citations

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells

2012 • 462 citations

Cross-presentation in viral immunity and self-tolerance

2001 • 460 citations

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responsesin vitroandin vivo

1998 • 457 citations

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

2006 • 454 citations

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

2001 • 454 citations

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+regulatory T cells

2005 • 451 citations

Inaugural Article : avoiding horror autotoxicus. The importance of dendritic cells in peripheral T cell tolerance

2002 • 448 citations

CD4+ Tregs and immune control

2004 • 417 citations

Tumor infiltrating Foxp3⁺ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

2006 • 410 citations

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

2001 • 407 citations

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.

2003 • 401 citations

In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity

2004 • 384 citations

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection

2001 • 374 citations

Migration of human dendritic cells after injection in patients with metastatic malignancies.

1999 • 353 citations

Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients

2001 • 346 citations

Bone marrow as a priming site for T-cell responses to blood-borne antigen

2003 • 343 citations

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generatedin vitro from CD34+ hematopoietic progenitor cells

2000 • 337 citations

Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade

2005 • 331 citations

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

2003 • 323 citations

Emerging clinical applications of RNA

2002 • 321 citations

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

2003 • 318 citations

CD4+ Tregs and immune control

2004 • 316 citations

Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

2005 • 293 citations

Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro

2006 • 292 citations

Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells

2000 • 292 citations

Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

1999 • 283 citations

The First 1000 Dendritic Cell Vaccinees

2003 • 277 citations

A Clinical Development Paradigm for Cancer Vaccines and Related Biologics

2006 • 272 citations

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

2005 • 271 citations

Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

2006 • 261 citations

Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity

2006 • 260 citations

Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.

2003 • 257 citations

CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2

2003 • 247 citations

Depletion of CD4⁺CD25⁺ human regulatory T cells in vivo: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro

2007 • 244 citations

Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo

2006 • 243 citations

Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity

2006 • 233 citations

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by geneMAGE-3

2001 • 222 citations

Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control

2003 • 221 citations

A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.

2002 • 219 citations

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo

2007 • 210 citations

The Roles of the New Negative T Cell Costimulatory Pathways in Regulating Autoimmunity

2004 • 208 citations

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

2002 • 206 citations

Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells

2000 • 202 citations

Toll-like receptors on regulatory T cells: expanding immune regulation

2006 • 201 citations

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

2002 • 201 citations

Regulatory T-cell therapy: is it ready for the clinic?

2005 • 195 citations

Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules

2004 • 192 citations

Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma

2003 • 192 citations

Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA

2006 • 189 citations

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine

2003 • 186 citations

Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome

2005 • 183 citations

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs

2004 • 183 citations

Phase 1 Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From the Melanoma-Associated Antigens MART-1 and gp100

2000 • 179 citations

Induction of carcinoembryonic antigen (cea)-specific cytotoxic t-lymphocyte responsesIn vitro using autologous dendritic cells loaded with cea peptide or cea rna in patients with metastatic malignancies expressing cea

1999 • 176 citations

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs

2004 • 175 citations

Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine

2006 • 174 citations

Phase I Trial Of Intravenous Peptide-Pulsed Dendritic Cells in Patients With Metastatic Melanoma

2001 • 171 citations

Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8⁺T-Cell Function in Melanoma Patients

2003 • 169 citations

Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells

2001 • 156 citations

Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells

2007 • 156 citations

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

2004 • 155 citations

Phenotypical and Functional Characterization of Clinical Grade Dendritic Cells

2002 • 154 citations

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

2000 • 152 citations

Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.

2002 • 149 citations

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration

2008 • 149 citations

CpG Oligodeoxynucleotide Enhances Tumor Response to Radiation

2004 • 146 citations

'Educated' dendritic cells act as messengers from memory to naive T helper cells

2004 • 140 citations

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

2005 • 138 citations

Immune and Clinical Outcomes in Patients with Stage IV Melanoma Vaccinated with Peptide-Pulsed Dendritic Cells Derived From CD34+ Progenitors and Activated with Type I Interferon

2005 • 131 citations

Migration of dendritic cell based cancer vaccines: in vivo veritas?

2005 • 131 citations

Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation

2005 • 128 citations

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells

2005 • 123 citations

Dendritic Cells Strongly Boost the Antitumor Activity of Adoptively Transferred T Cells In vivo

2004 • 121 citations

Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy

2004 • 119 citations

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma

2004 • 118 citations

Evaluation of in vivo labelled dendritic cell migration in cancer patients.

2004 • 117 citations

Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells

2004 • 115 citations

Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells

2005 • 114 citations

From plasmacytoid to dendritic cell: Morphological and functional switches during plasmacytoid pre‐dendritic cell differentiation

2006 • 110 citations

Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients

2005 • 104 citations

Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after FcγRII-mediated uptake

2006 • 101 citations

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

2006 • 94 citations

Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes.

2003 • 92 citations

Enhancement of Immunologic Tumor Regression by Intratumoral Administration of Dendritic Cells in Combination with Cryoablative Tumor Pretreatment and Bacillus Calmette-Guerin Cell Wall Skeleton Stimulation

2006 • 90 citations

Cranking the Immunologic Engine with Chemotherapy: Using Context to Drive Tumor Antigen Cross-Presentation towards Useful Antitumor Immunity

2006 • 89 citations

The role of natural killer cells in tumor control—effectors and regulators of adaptive immunity

2005 • 85 citations

Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity

2004 • 82 citations

Dendritic cells generated in the presence of GM‐CSF plus IL‐15 prime potent CD8⁺ Tc1 responses in vivo

2003 • 77 citations

Visualization of a primary anti-tumor immune response by positron emission tomography

2005 • 76 citations

Blood Dendritic Cells Generated With Flt3 Ligand and CD40 Ligand Prime CD8+ T Cells Efficiently in Cancer Patients

2006 • 71 citations

Dendritic cells under the spell of prostaglandins

2003 • 65 citations

A Protocol for Generation of Clinical Grade mRNA‐Transfected Monocyte‐Derived Dendritic Cells for Cancer Vaccines

2003 • 65 citations

Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen

2003 • 64 citations

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

2006 • 64 citations

Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients

2006 • 63 citations

Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen

2003 • 60 citations

Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination

2005 • 59 citations

Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results

2004 • 58 citations

A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients

2005 • 56 citations

Induction of strong and persistent MelanA/MART‐1‐specific immune responses by adjuvant dendritic cell‐based vaccination of stage II melanoma patients

2005 • 55 citations

mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation

2002 • 55 citations

Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4

2005 • 53 citations

Phenotypical and Functional Characterization of Clinical-Grade Dendritic Cells

2004 • 47 citations

Efficient Chemokine-dependent Migration and Primary and Secondary IL-12 Secretion by Human Dendritic Cells Stimulated Through Toll-like Receptors

2007 • 43 citations

5-Fluorouracil–Based Chemotherapy Enhances the Antitumor Activity of a Thymidylate Synthase–Directed Polyepitopic Peptide Vaccine

2005 • 43 citations

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

2006 • 42 citations

T Cell Immunity Induced by Live, Necrotic, and Apoptotic Tumor Cells

2004 • 40 citations

Potential functional role of plasmacytoid dendritic cells in cancer immunity

2007 • 37 citations

Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8+ Immunity

2005 • 33 citations

Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses

2004 • 28 citations

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

2004 • 27 citations

Cellular adoptive immunotherapy after allogeneic stem cell transplantation

2005 • 26 citations

The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity

2007 • 22 citations

Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination

2006 • 12 citations

A phase II trial of denileukin diftitox to treat refractory advanced-stage ovarian cancer

2006 • 5 citations

Uncertainty surrounds cancer vaccine review at FDA

2007 • 5 citations

DAB(389)IL2 (denileukin diftitox) suppresses growth of melanoma metastases

2006 • 1 citations